Terms: = Germ cell tumor AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
333 results:
1. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
2. Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness.
Kardoust Parizi M; Margulis V; Bagrodia A; Bekku K; Klemm J; Matsukawa A; Alimohammadi A; Motlagh RS; Mostafaei H; Laukhtina E; Shariat SF
Urol Oncol; 2024 Apr; 42(4):102-109. PubMed ID: 38360519
[TBL] [Abstract] [Full Text] [Related]
3. Long-Term Outcomes of Infantile Sacrococcygeal Teratoma: Results from a Multi-Institutional Retrospective Observational Study in Japan.
Fumino S; Hirohata Y; Takayama S; Tajiri T; Usui N; Taguchi T;
J Pediatr Surg; 2024 Apr; 59(4):587-592. PubMed ID: 38158258
[TBL] [Abstract] [Full Text] [Related]
4. Strong apoptotic response of testis tumor cells following cisplatin treatment.
Köberle B; Usanova S; Piee-Staffa A; Heinicke U; Clauss P; Brozovic A; Kaina B
Int Urol Nephrol; 2024 Mar; 56(3):1007-1017. PubMed ID: 37891379
[TBL] [Abstract] [Full Text] [Related]
5. Digital spatial profiling of melanoma shows cd95 expression in immune cells is associated with resistance to immunotherapy.
Martinez-Morilla S; Moutafi M; Fernandez AI; Jessel S; Divakar P; Wong PF; Garcia-Milian R; Schalper KA; Kluger HM; Rimm DL
Oncoimmunology; 2023; 12(1):2260618. PubMed ID: 37781235
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
7. Co-administration with A1M does not influence apoptotic response of
Rassol N; Andersson C; Pettersson D; Al-Awar A; Shubbar E; Kovács A; Åkerström B; Gram M; Helou K; Forssell-Aronsson E
Sci Rep; 2023 Apr; 13(1):6417. PubMed ID: 37076494
[TBL] [Abstract] [Full Text] [Related]
8. Erianin as a Promising Novel Agent in the treatment of Neuroblastoma: The Anticancer Effects and Underlying Molecular Mechanisms.
Kocoglu SS; Seçme M; Sunay FB
Anticancer Agents Med Chem; 2023; 23(10):1204-1210. PubMed ID: 36852793
[TBL] [Abstract] [Full Text] [Related]
9. Postoperative Echography for Optimization of Radiation Dosimetry in Patients with Uveal Melanoma Treated with Plaque Brachytherapy.
Binkley EM; King BA; Hyer DE; Javed A; Milhem MM; Hinz CJ; Mott SL; Boldt HC
Ophthalmol Retina; 2023 Jul; 7(7):620-627. PubMed ID: 36822323
[TBL] [Abstract] [Full Text] [Related]
10. The FOXO1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells.
Flores D; Lopez A; Udawant S; Gunn B; Keniry M
FEBS Open Bio; 2023 Feb; 13(2):352-362. PubMed ID: 36602390
[TBL] [Abstract] [Full Text] [Related]
11. The Pakistan Brain Tumour Epidemiology Study.
Enam SA; Shah MM; Bajwa MH; Khalid MU; Bakhshi SK; Baig E; Altaf IA; Laghari AA; Anis SB; Akhunzada NZ; Raghib MF; Gilani JA; Jawed N; ; Siddiqi S;
J Pak Med Assoc; 2022 Nov; 72(Suppl 4)(11):S4-S11. PubMed ID: 36591621
[TBL] [Abstract] [Full Text] [Related]
12. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity.
Gu Y; Lin X; Dong Y; Wood G; Seidah NG; Werstuck G; Major P; Bonert M; Kapoor A; Tang D
J Exp Clin Cancer Res; 2023 Jan; 42(1):2. PubMed ID: 36588164
[TBL] [Abstract] [Full Text] [Related]
13. Detection and evolutionary dynamics of somatic fas variants in autoimmune lymphoproliferative syndrome: Diagnostic implications.
Batlle-Masó L; Garcia-Prat M; Parra-Martínez A; Franco-Jarava C; Aguiló-Cucurull A; Velasco P; Antolín M; Rivière JG; Martín-Nalda A; Soler-Palacín P; Martínez-Gallo M; Colobran R
Front Immunol; 2022; 13():1014984. PubMed ID: 36466883
[TBL] [Abstract] [Full Text] [Related]
14. Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma.
Cartun Z; Kunz WG; Heinzerling L; Tomsitz D; Guertler A; Westphalen CB; Ricke J; Weir W; Unterrainer M; Mehrens D
JAMA Dermatol; 2022 Dec; 158(12):1387-1393. PubMed ID: 36260321
[TBL] [Abstract] [Full Text] [Related]
15. PD-1 and CTLA-4 inhibitors in combination vs. alone for the treatment of advanced melanoma: A systematic review and meta-analysis.
He R; Zhao X; Liu J; Zhou Y; Zhang X; Cheng F
Medicine (Baltimore); 2022 Oct; 101(41):e30561. PubMed ID: 36254050
[TBL] [Abstract] [Full Text] [Related]
16. Extrinsic apoptosis and senescence involved in growth kinetics of seminoma to cisplatin.
Yin Y; Peng J; Zheng X; Zhou J; Wang Y; Dai Y; Yin G; Tang Y
Clin Exp Pharmacol Physiol; 2023 Feb; 50(2):140-148. PubMed ID: 36222180
[TBL] [Abstract] [Full Text] [Related]
17. Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort Study.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Neurology; 2022 Sep; 99(10):e999-e1008. PubMed ID: 36219797
[TBL] [Abstract] [Full Text] [Related]
18. (20S) Ginsenoside Rh2-Activated, Distinct Apoptosis Pathways in Highly and Poorly Differentiated Human Esophageal Cancer cells.
Li H; Han C; Chen C; Han G; Li Y
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080369
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing tumors: A 2-Year Follow-Up.
Duan H; Ferri V; Fisher GA; Shaheen S; Davidzon GA; Iagaru A; Mari Aparici C
Oncologist; 2022 Jun; 27(6):447-452. PubMed ID: 35641196
[TBL] [Abstract] [Full Text] [Related]
20. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract] [Full Text] [Related]
[Next]
